119 related articles for article (PubMed ID: 12531521)
1. Differences in the activation of the GFAP gene promoter by prion and viral infections.
Titeux M; Galou M; Gomes FC; Dormont D; Neto VM; Paulin D
Brain Res Mol Brain Res; 2002 Dec; 109(1-2):119-27. PubMed ID: 12531521
[TBL] [Abstract][Full Text] [Related]
2. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes.
Johnson WB; Ruppe MD; Rockenstein EM; Price J; Sarthy VP; Verderber LC; Mucke L
Glia; 1995 Mar; 13(3):174-84. PubMed ID: 7782103
[TBL] [Abstract][Full Text] [Related]
3. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.
Lee Y; Su M; Messing A; Brenner M
Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522
[TBL] [Abstract][Full Text] [Related]
4. Normal and pathological expression of GFAP promoter elements in transgenic mice.
Galou M; Pournin S; Ensergueix D; Ridet JL; Tchélingérian JL; Lossouarn L; Privat A; Babinet C; Dupouey P
Glia; 1994 Dec; 12(4):281-93. PubMed ID: 7890332
[TBL] [Abstract][Full Text] [Related]
5. AP-1 and the injury response of the GFAP gene.
Brenner M; Messing A; Olsen ML
J Neurosci Res; 2019 Feb; 97(2):149-161. PubMed ID: 30345544
[TBL] [Abstract][Full Text] [Related]
6. GFAP promoter directs astrocyte-specific expression in transgenic mice.
Brenner M; Kisseberth WC; Su Y; Besnard F; Messing A
J Neurosci; 1994 Mar; 14(3 Pt 1):1030-7. PubMed ID: 8120611
[TBL] [Abstract][Full Text] [Related]
7. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
[TBL] [Abstract][Full Text] [Related]
8. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury.
Mucke L; Oldstone MB; Morris JC; Nerenberg MI
New Biol; 1991 May; 3(5):465-74. PubMed ID: 1883812
[TBL] [Abstract][Full Text] [Related]
9. GFAP promoter elements required for region-specific and astrocyte-specific expression.
Lee Y; Messing A; Su M; Brenner M
Glia; 2008 Apr; 56(5):481-93. PubMed ID: 18240313
[TBL] [Abstract][Full Text] [Related]
10. Abnormal activation of glial cells in the brains of prion protein-deficient mice ectopically expressing prion protein-like protein, PrPLP/Dpl.
Atarashi R; Sakaguchi S; Shigematsu K; Arima K; Okimura N; Yamaguchi N; Li A; Kopacek J; Katamine S
Mol Med; 2001 Dec; 7(12):803-9. PubMed ID: 11844868
[TBL] [Abstract][Full Text] [Related]
11. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
[TBL] [Abstract][Full Text] [Related]
12. Dual transgenic reporter mice as a tool for monitoring expression of glial fibrillary acidic protein.
Cho W; Hagemann TL; Johnson DA; Johnson JA; Messing A
J Neurochem; 2009 Jul; 110(1):343-51. PubMed ID: 19457099
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of a glial fibrillary acidic protein-LacZ transgene in retinal astrocytes and Müller cells.
Verderber L; Johnson W; Mucke L; Sarthy V
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1137-43. PubMed ID: 7730023
[TBL] [Abstract][Full Text] [Related]
14. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M
J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of glial fibrillary acidic protein fragments and mu-calpain activation within the hippocampus of prion-infected mice.
Gray BC; Skipp P; O'Connor VM; Perry VH
Biochem Soc Trans; 2006 Feb; 34(Pt 1):51-4. PubMed ID: 16417481
[TBL] [Abstract][Full Text] [Related]
16. GFAP promoter drives Müller cell-specific expression in transgenic mice.
Kuzmanovic M; Dudley VJ; Sarthy VP
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3606-13. PubMed ID: 12882814
[TBL] [Abstract][Full Text] [Related]
17. Glial fibrillary acidic protein transcription responses to transforming growth factor-beta1 and interleukin-1beta are mediated by a nuclear factor-1-like site in the near-upstream promoter.
Krohn K; Rozovsky I; Wals P; Teter B; Anderson CP; Finch CE
J Neurochem; 1999 Apr; 72(4):1353-61. PubMed ID: 10098836
[TBL] [Abstract][Full Text] [Related]
18. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions.
Sousa Vde O; Romão L; Neto VM; Gomes FC
Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546
[TBL] [Abstract][Full Text] [Related]
19. A 1.8kb GFAP-promoter fragment is active in specific regions of the embryonic CNS.
Andrae J; Bongcam-Rudloff E; Hansson I; Lendahl U; Westermark B; Nistér M
Mech Dev; 2001 Sep; 107(1-2):181-5. PubMed ID: 11520676
[TBL] [Abstract][Full Text] [Related]
20. Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter.
Morimoto S; Cassell MD; Beltz TG; Johnson AK; Davisson RL; Sigmund CD
Circ Res; 2001 Aug; 89(4):365-72. PubMed ID: 11509454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
